RN7SL403P

Across TCGA pan-cancer cohorts, RN7SL403P RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RN7SL403P data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RN7SL403P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RN7SL403P expression acts as an unfavorable survival marker, although some lineages such as LUAD and READ show a favorable association.

LUAD, LGG, and UCEC are the cancer types where RN7SL403P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.759	0.611	<.001	109	view →
LGG	DFS	Median	All	0.311	0.457	<.001	46	view →
UCEC	DFS	Quartile	All	0.771	0.870	.010	40	view →
LIHC	DFS	Quartile	All	0.429	0.604	<.001	31	view →
READ	OS	Median	III,IV	0.813	0.278	<.001	28	view →
UCS	OS	Quartile	II,III,IV	0.766	0.354	.003	24	view →
PAAD	DFS	Tertile	All	0.479	0.297	.024	24	view →
STAD	OS	Tertile	III,IV	0.675	0.351	.003	15	view →
ACC	DFS	Median	IV	0.170	0.522	.010	15	view →
SKCM	DFS	Median	III,IV	0.404	0.125	<.001	13	view →
KICH	OS	Tertile	All	0.677	1.000	.030	10	view →
MESO	OS	Median	II,III,IV	0.492	0.304	.008	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RN7SL403P–LUAD (OS)

Open the LUAD breakdown →